$KPTI· SEC filing ·

KPTI Q1 2026 Revenue $35.1M, XPOVIO Net $29.2M, Guides FY2026 $130-150M

Karyopharm Therapeutics Inc. · PHARMACEUTICAL PREPARATIONS · Now $9.82

-16% in 3d after detection

Post-detection moves

1h
1d
-14%
3d
-16%
7d
+0.8%
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS